Scotia Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.31M | Buy |
31,792
+2,618
| +9% | +$860K | 0.04% | 222 |
|
|
2025
Q4 | $10.2M | Buy |
29,174
+868
| +3% | +$293K | 0.04% | 208 |
|
|
2025
Q3 | $9.15M | Buy |
28,306
+5,494
| +24% | +$1.71M | 0.04% | 212 |
|
|
2025
Q2 | $8.87M | Buy |
22,812
+1,202
| +6% | +$483K | 0.04% | 207 |
|
|
2025
Q1 | $9.4M | Sell |
21,610
-2,881
| -12% | -$1.16M | 0.05% | 193 |
|
|
2024
Q4 | $9.04M | Buy |
24,491
+3,583
| +17% | +$1.5M | 0.05% | 188 |
|
|
2024
Q3 | $10.9M | Buy |
20,908
+796
| +4% | +$425K | 0.06% | 168 |
|
|
2024
Q2 | $10.9M | Buy |
20,112
+1,635
| +9% | +$864K | 0.06% | 161 |
|
|
2024
Q1 | $9.58M | Buy |
18,477
+2,790
| +18% | +$1.39M | 0.06% | 171 |
|
|
2023
Q4 | $7.4M | Buy |
15,687
+940
| +6% | +$435K | 0.05% | 190 |
|
|
2023
Q3 | $6.42M | Buy |
14,747
+3,720
| +34% | +$1.69M | 0.05% | 198 |
|
|
2023
Q2 | $4.9M | Buy |
11,027
+4,817
| +78% | +$2.22M | 0.03% | 229 |
|
|
2023
Q1 | $2.86M | Buy |
6,210
+100
| +2% | +$47.6K | 0.02% | 301 |
|
|
2022
Q4 | $3.13M | Sell |
6,110
-442
| -7% | -$224K | 0.02% | 288 |
|
|
2022
Q3 | $2.98M | Sell |
6,552
-516
| -7% | -$247K | 0.02% | 282 |
|
|
2022
Q2 | $3.41M | Sell |
7,068
-8,047
| -53% | -$3.98M | 0.03% | 278 |
|
|
2022
Q1 | $7.42M | Sell |
15,115
-69
| -0.5% | -$31.5K | 0.05% | 198 |
|
|
2021
Q4 | $7.04M | Sell |
15,184
-447
| -3% | -$188K | 0.05% | 206 |
|
|
2021
Q3 | $5.83M | Buy |
15,631
+827
| +6% | +$314K | 0.04% | 225 |
|
|
2021
Q2 | $5.65M | Sell |
14,804
-3,506
| -19% | -$1.34M | 0.04% | 234 |
|
|
2021
Q1 | $6.57M | Buy |
18,310
+116
| +0.6% | +$37.3K | 0.05% | 198 |
|
|
2020
Q4 | $5.84M | Buy |
18,194
+1,012
| +6% | +$311K | 0.05% | 188 |
|
|
2020
Q3 | $4.62M | Buy |
+17,182
| New | +$4.62M | 0.05% | 197 |
|
|
2020
Q2 | – | Sell |
-15,567
| Closed | -$3.53M | – | 674 |
|
|
2020
Q1 | $3.53M | Buy |
15,567
+529
| +4% | +$144K | 0.05% | 188 |
|
|
2019
Q4 | $4.54M | Sell |
15,038
-413
| -3% | -$114K | 0.05% | 184 |
|
|
2019
Q3 | $3.71M | Sell |
15,451
-408
| -3% | -$112K | 0.04% | 204 |
|
|
2019
Q2 | $4.48M | Buy |
15,859
+7,061
| +80% | +$1.93M | 0.05% | 181 |
|
|
2019
Q1 | $2.52M | Buy |
8,798
+450
| +5% | +$130K | 0.03% | 246 |
|
|
2018
Q4 | $2.19M | Sell |
8,348
-190
| -2% | -$52.2K | 0.03% | 254 |
|
|
2018
Q3 | $2.34M | Buy |
8,538
+48
| +0.6% | +$12.5K | 0.03% | 270 |
|
|
2018
Q2 | $1.85M | Buy |
8,490
+216
| +3% | +$50K | 0.03% | 294 |
|
|
2018
Q1 | $1.82M | Buy |
8,274
+1,704
| +26% | +$400K | 0.03% | 302 |
|
|
2017
Q4 | $1.48M | Buy |
6,570
+64
| +1% | +$13.6K | 0.02% | 347 |
|
|
2017
Q3 | $1.24M | Buy |
6,506
+62
| +1% | +$11.8K | 0.02% | 351 |
|
|
2017
Q2 | $1.21M | Sell |
6,444
-177
| -3% | -$31.8K | 0.02% | 330 |
|
|
2017
Q1 | $1.1M | Sell |
6,621
-2,524
| -28% | -$402K | 0.02% | 361 |
|
|
2016
Q4 | $1.31M | Buy |
9,145
+124
| +1% | +$16.6K | 0.02% | 370 |
|
|
2016
Q3 | $1.13M | Buy |
9,021
+855
| +10% | +$110K | 0.02% | 394 |
|
|
2016
Q2 | $1.07M | Buy |
8,166
+1,104
| +16% | +$151K | 0.02% | 370 |
|
|
2016
Q1 | $982K | Sell |
7,062
-835
| -11% | -$112K | 0.02% | 361 |
|
|
2015
Q4 | $1.09M | Hold |
7,897
| – | – | 0.02% | 396 |
|
|
2015
Q3 | $1.1M | Sell |
7,897
-804
| -9% | -$121K | 0.03% | 369 |
|
|
2015
Q2 | $1.42M | Buy |
8,701
+3,071
| +55% | +$491K | 0.03% | 331 |
|
|
2015
Q1 | $870K | Buy |
+5,630
| New | +$802K | 0.02% | 332 |
|
|
2014
Q4 | – | Sell |
-5,701
| Closed | -$681K | – | 590 |
|
|
2014
Q3 | $681K | Sell |
5,701
-5
| -0.1% | -$573 | 0.01% | 369 |
|
|
2014
Q2 | $614K | Buy |
5,706
+219
| +4% | +$22.6K | 0.01% | 372 |
|
|
2014
Q1 | $546K | Buy |
+5,487
| New | +$496K | 0.01% | 388 |
|
|
2013
Q3 | – | Sell |
-24,150
| Closed | -$1.98M | – | 495 |
|
|
2013
Q2 | $1.98M | Buy |
+24,150
| New | +$1.81M | 0.08% | 164 |
|
Other funds holding ELV
VCM
VPM
Scotia Capital's ELV Position: Q1 2026 in Review
Scotia Capital increased its Elevance Health (ELV) stake by 9% in Q1 2026, buying an estimated $860K and bringing the position to 31,792 shares worth $9.31M. The position accounts for 0.04% of the portfolio, ranked #222.
Scotia Capital first reported a position in ELV in Q2 2013 and has held it in 48 quarters since. The position peaked at $10.9M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Scotia Capital held 31,792 shares of Elevance Health worth $9.31M as of Q1 2026.
- Scotia Capital bought 2,618 Elevance Health shares in Q1 2026, an estimated $860K.
- Elevance Health made up 0.04% of Scotia Capital's portfolio in Q1 2026, its #222 holding.
- Scotia Capital first reported a position in Elevance Health in Q2 2013 and has held it in 48 quarters since.
- Scotia Capital's Elevance Health position peaked at $10.9M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.